The Journal of Organic Chemistry
Article
1
tert-Butyl [2-[1-(tert-Butylperoxy)-4-oxocyclohexa-2,5-dien-1-yl]-
hexane (1:1:16)); colorless oil; H NMR (500 MHz, CDCl3) δ 6.91
(d, J = 10.3 Hz, 1H), 5.99 (d, J = 10.3 Hz, 1H), 4.60 (dd, J = 12.2, 5.1
Hz, 1H), 3.90−3.72 (m, 1H), 2.94 (dd, J = 16.1, 12.2 Hz, 1H), 2.70
(dd, J = 16.2, 5.1 Hz, 1H), 2.14−1.99 (m, 1H), 1.83−1.70 (m, 1H),
1.67−1.53 (m, 1H), 1.49 (dd, J = 13.2, 3.3 Hz, 1H), 1.23 (s, 9H), 1.21
(t, J = 6.3 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 198.3, 153.5,
129.2, 80.0, 77.3, 70.1, 65.3, 40.1, 27.9, 27.2, 26.5, 21.1; EI-HRMS:
calculated for C14H22O4 (M + H), 255.15972; found 255.15974.
(3aR,7aR)-3a-(tert-Butylperoxy)-3,3a,7,7a-tetrahydro-1-benzo-
furan-2,6-dione (22): 192 mg, 40%, Rf 0.30 (EtOAc/DCM/hexane
ethyl]carbamate (13): 384 mg, 59%, Rf 0.30 (EtOAc/DCM/hexane
1
(1:1:1)); colorless oil; H NMR (500 MHz, CDCl3) δ 6.91 (d, J =
10.1 Hz, 2H), 6.28 (d, J = 10.1 Hz, 2H), 4.68 (s, 1H), 3.18 (br d, J =
6.3 Hz, 2H), 1.93 (t, J = 7.1 Hz, 2H), 1.43 (br s, 9H), 1.20 (s, 9H);
13C NMR (126 MHz, CDCl3) δ 185.5, 149.5, 130.0, 80.8, 80.4, 79.5,
78.0, 36.9, 35.9, 28.4, 26.3; EI-HRMS: calculated for C17H27O5N (M +
H), 326.19675; found, 326.19541.
General Procedure for Tandem Phenol Oxidation−Michael
Addition Sequence. 4-(tert-Butyldioxy)cyclohexa-2,5-dienone (2.0
mmol), [Rh2(cap)4] (0.02 mmol, 0.01 equiv), and DCE (4.0 mL)
were placed in a 4-dram screw-cap vial containing a magnetic stirring
bar. The suspension containing a small amount of undissolved phenol
derivative and Rh2(cap)4 was heated to 40 °C in an oil bath at 250
rpm, and T-HYDRO was added all at once via syringe. The vial
containing the reaction mixture was loosely capped to allow release of
pressure built-up, and its contents were stirred using a magnetic
stirring bar at 40 °C. All solid materials dissolved within 10 min of T-
HYDRO addition. After 90 min, the reaction mixture was allowed to
cool to room temperature, and anhydrous Na2SO4 (600 mg), followed
by TsOH or (rac)-BINOL-PO2H (0.20 mmol, 0.1 equiv), was added
to the mixture. The suspension was stirred overnight at room
temperature, then transferred to a 100-mL round-bottom flask and
concentrated under reduced pressure, and the residue was purified by
column chromatography (silica gel, DCM/AcOEt/hexane). Fractions
containing the product were combined, and the solvent was
evaporated under reduced pressure. The peroxide product was dried
under high vacuum for 20 min (0.09 Torr, room temperature).
(3aR,7aR)-3a-(tert-Butylperoxy)-3,3a,7,7a-tetrahydro-1-benzo-
furan-6(2H)-one (16): 280 mg, 62%, Rf 0.14 (EtOAc/DCM/hexane
1
(1:1:4)); colorless oil; H NMR (500 MHz, CDCl3) δ 6.75 (dd, J =
10.3, 1.2 Hz, 1H), 6.24 (d, J = 10.3 Hz, 1H), 5.11 (dd, J = 8.2, 1.2 Hz,
1H), 3.24−2.97 (comp, 2H), 2.89−2.65 (comp, 2H), 1.24 (s, 9H);
13C NMR (126 MHz, CDCl3) δ 193.5, 171.4, 144.0, 131.5, 81.4, 80.4,
78.7, 40.4, 38.7, 26.3; EI-HRMS: calculated for C12H16O5 (M + H),
241.10760; found, 241.10701.
(2S,3aR,7aR)-1-(tert-Butoxycarbonyl)-3a-(tert-butylperoxy)-6-
oxo-2,3,3a,6,7,7a-hexahydro-1H-indole-2-carboxylic acid (24): 310
mg, 42%, Rf 0.36 (DCM/MeOH (9:1)); colorless oil; H NMR (500
MHz, CDCl3) δ 10.14 (br s, 1H), 6.98−6.81 (m, 1H), 6.09 (d, J = 10.4
Hz, 1H), 4.82−4.63 (m, 1H), 4.63−4.43 (m, 1H), 3.43−3.14 (m, 1H),
2.85−2.56 (m, 1H), 2.55−2.26 (comp, 2H), 1.54−1.40 (comp, 9H),
1.23−1.18 (comp, 9H); 13C NMR (126 MHz, CDCl3) δ 196.0, 195.8,
175.8, 172.9, 155.6, 153.0, 148.2, 146.7, 130.5, 130.3, 85.2, 84.4, 82.6,
81.0, 80.8, 80.7, 59.6, 59.2, 58.5, 58.1, 42.2, 41.5, 37.5, 35.8, 28.4, 28.1,
26.7, 26.3; EI-HRMS: calculated for C18H27NO7 (M + H), 370.18668;
found, 370.18606.
1
tert-Butyl (3aR,7aR)-3a-(tert-Butylperoxy)-6-oxo-2,3,3a,6,7,7a-
hexahydro-1H-indole-1-carboxylate (29): 358 mg, 55%, Rf 0.34
(EtOAc/DCM/hexane (1:1:4)); colorless oil; H NMR (500 MHz,
1
1
(1:1:8)); colorless oil; H NMR (500 MHz, CDCl3) δ 6.77 (dd, J =
CDCl3) δ 7.08−6.79 (m, 1H), 6.06 (d, J = 10.4 Hz, 1H), 4.77−4.50
(m, 1H), 3.70−3.41 (m, 2H), 3.24−2.96 (m, 1H), 2.51−2.31 (m, 1H),
2.31−2.19 (m, 1H), 2.19−2.02 (m, 1H), 1.46 (s, 9H), 1.21 (s, 9H);
13C NMR (126 MHz, CDCl3) δ 197.0, 154.1, 148.9, 130.1, 86.1, 80.4,
80.1, 77.2, 58.7, 44.7, 42.7, 32.6, 28.4, 26.4; EI-HRMS: calculated for
C17H27NO5 (M + H), 326.19685; found, 326.19641. The enantio-
meric excess was determined by HPLC on an AD-H column (97:3
hexanes/i-PrOH, 1.0 mL/min): tR (major) = 7.04 min; tR (minor) =
8.84 min.
10.3, 1.6 Hz, 1H), 6.09 (d, J = 10.3 Hz, 1H), 4.46 (td, J = 5.0, 1.6 Hz,
1H), 3.96 (dd, J = 7.8, 6.7 Hz, 2H), 2.87 (dd, J = 16.9, 5.0 Hz, 1H),
2.68 (dd, J = 16.9, 4.4 Hz, 1H), 2.32 (dt, J = 13.5, 6.7 Hz, 1H), 2.08
(dt, J = 13.5, 7.8 Hz, 1H), 1.23 (s, 9H); 13C NMR (126 MHz, CDCl3)
δ 196.7 (C), 147.4 (CH), 129.7 (CH), 84.2 (C), 80.2 (C), 79.2 (CH),
66.0 (CH2), 41.3 (CH2), 36.9 (CH2), 26.4 (CH3); IR (neat, cm−1):
3034, 2877, 2932, 2881, 1688, 1386, 1363, 1190, 1067, 1017, 877; ESI-
HRMS: calculated for C12H18O4 (M + H), 227.12841; found,
227.12817. The enantiomeric excess was determined by HPLC on
an AD-H column (80:20 hexanes/i-PrOH, 1.0 mL/min): tR (major) =
4.13 min; tR (minor) = 4.75 min.
1-tert-Butyl 2-Methyl (2S,3aR,7aR)-3a-(tert-Butylperoxy)-6-oxo-
2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (31): 132 mg,
35%, Rf 0.23 (EtOAc/DCM/hexane (1:1:4)); colorless oil; H NMR
1
(4aR,8aR)-4a-(tert-Butylperoxy)-2,3,4,4a,8,8a-hexahydro-7H-
(600 MHz, CDCl3) δ 6.94−6.85 (m, 1H), 6.09−6.03 (m, 1H), 4.85−
4.61 (m, 1H), 4.55−4.39 (m, 1H), 3.81−3.71 (comp, 3H), 3.28−3.03
(m, 1H), 2.81−2.56 (comp, 2H), 2.27−2.11 (m, 1H), 1.47−1.39
(comp, 9H), 1.24−1.19 (comp, 9H); 13C NMR (126 MHz, CDCl3) δ
196.3, 196.1, 171.4, 170.5, 153.5, 153.0, 147.7, 146.9, 130.4, 130.1,
129.5, 125.7, 85.5, 84.3, 80.9, 80.8, 80.6, 80.5, 59.2, 58.2, 57.8, 52.1,
52.0, 42.7, 41.5, 37.6, 36.7, 28.4, 28.2, 26.3; EI-HRMS: calculated for
C19H29NO7 (M + H), 384.20222; found, 384.20319.
chromen-7-one (18): 250 mg, 52%, Rf 0.08 (EtOAc/DCM/hexane
1
(1:1:4)); colorless oil; H NMR (500 MHz, CDCl3) δ 6.53 (dd, J =
10.2, 2.0 Hz, 1H), 6.15 (d, J = 10.2 Hz, 1H), 4.06 (td, J = 3.9, 2.0 Hz,
1H), 3.92 − 3.80 (m, 1H), 3.44 (td, J = 11.1, 2.7 Hz, 1H), 3.00 (dd, J
= 16.8, 3.5 Hz, 1H), 2.57 (dd, J = 16.8, 4.2 Hz, 1H), 2.10 − 1.93
(comp, 2H), 1.79−1.67 (m, 1H), 1.68−1.54 (m, 1H), 1.21 (s, 9H);
13C NMR (126 MHz, CDCl3) δ 197.6 (C), 147.1 (CH), 132.5 (CH),
79.9 (C), 75.7 (C), 75.3 (CH), 66.3 (CH2), 41.1 (CH2), 31.9 (CH2),
26.5 (CH3), 22.9 (CH2); EI-HRMS: calculated for C13H20O4 (M +
H), 241.14394; found, 241.14362. The enantiomeric excess was
determined by separation on a HPLC on an AD-H column (90:10
hexanes/i-PrOH, 1.0 mL/min): tR (major) = 4.51 min; tR (minor) =
5.35 min.
(2S,4aR,8aR)-4a-(tert-Butylperoxy)-2-methyl-2,3,4,4a,8,8a-hexa-
hydro-7H-chromen-7-one (20): 254 mg, 52%, Rf 0.26 (EtOAc/
DCM/hexane (1:1:16)); colorless oil; 1H NMR (500 MHz, CDCl3) δ
6.46 (dd, J = 10.1, 2.4 Hz, 1H), 6.16 (d, J = 10.1 Hz, 1H), 4.01 (dd, J =
5.5, 2.4 Hz, 1H), 3.50 (dtd, J = 12.1, 6.1, 4.2 Hz, 1H), 3.03 (dd, J =
16.9, 3.3 Hz, 1H), 2.50 (dd, J = 16.9, 2.5 Hz, 1H), 2.13−1.92 (comp,
2H), 1.69 (dt, J = 13.6, 4.6 Hz, 1H), 1.38−1.24 (m, 1H), 1.20 (s, 9H),
1.12 (d, J = 6.2 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 197.7 (C),
146.1 (CH), 133.0 (CH), 79.9 (C), 75.8 (CH), 75.1 (C), 73.2 (CH),
41.5 (CH2), 32.8 (CH2), 30.6 (CH2), 26.5 (CH3), 21.3 (CH); EI-
HRMS: calculated for C14H22O4 (M + H), 255.15972; found,
255.15941.
1-tert-Butyl 2-Methyl (2S,3aS,7aS)-3a-(tert-Butylperoxy)-6-oxo-
2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (32): 83 mg,
1
21%, Rf 0.31 (EtOAc/DCM/hexane (1:1:4)); colorless oil; H NMR
(600 MHz, CDCl3) δ 6.92−6.82 (m, 1H), 6.12−6.05 (m, 1H), 4.79−
4.61 (m, 1H), 4.61−4.41 (m, 1H), 3.82−3.72 (comp, 3H), 3.40−3.14
(m, 1H), 2.67−2.51 (m, 1H), 2.51−2.42 (m, 1H), 2.41−2.27 (m, 1H),
1.53−1.40 (comp, 9H), 1.25−1.18 (comp, 9H); 13C NMR (126 MHz,
CDCl3) δ 196.6, 196.2, 172.9, 172.8, 153.6, 153.0, 147.6, 146.9, 130.6,
130.4, 129.6, 125.8, 85.8, 85.0, 80.9, 80.6, 59.7, 59.6, 59.5, 59.0, 52.5,
52.3, 42.6, 42.2, 38.0, 37.3, 28.4, 28.2, 26.4, 26.3; EI-HRMS: calculated
for C19H29NO7 (M + H), 384.20222; found, 384.20352.
Di-tert-butyl (2S,3aR,7aR)-3a-(tert-Butylperoxy)-6-oxo-
2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (34): 176 mg,
41%, Rf 0.27 (EtOAc/hexane (1:5)); colorless oil; 1H NMR (500
MHz, CDCl3) δ 6.90−6.80 (m, 1H), 6.11−6.02 (m, 1H), 4.83−4.63
(m, 1H), 4.45−4.26 (m, 1H), 3.39−3.11 (m, 1H), 2.65−2.38 (comp,
2H), 2.39−2.28 (m, 1H), 1.52−1.40 (comp, 18H), 1.27−1.19 (comp,
9H); 13C NMR (126 MHz, CDCl3) δ 196.6, 196.4, 169.1, 168.8,
153.3, 153.3, 148.3, 147.7, 130.2, 130.0, 85.5, 84.4, 81.3, 81.0, 80.8,
80.7, 80.5, 80.3, 59.4, 59.3, 58.5, 58.4, 42.6, 41.7, 37.9, 37.0, 28.4, 28.2,
(2R,4aR,8aR)-4a-(tert-Butylperoxy)-2-methyl-2,3,4,4a,8,8a-hexa-
hydro-7H-chromen-7-one (21): 36 mg, 7%, Rf 0.09 (EtOAc/DCM/
H
dx.doi.org/10.1021/jo302002j | J. Org. Chem. XXXX, XXX, XXX−XXX